TEC-话题@MedSci

#TEC#

484篇内容 | 2720人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1652314, encodeId=b16b165231447, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Health Technol Assess：难治性抑郁，SSRI或SNRI加用米氮平无效, objectType=article, longId=157762, objectId=918c15e762f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=918c15e762f2, replyNumber=0, likeNumber=70, createdTime=2019-05-03, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=918c15e762f2, moduleTitle=Health Technol Assess：难治性抑郁，SSRI或SNRI加用米氮平无效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=918c15e762f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652368, encodeId=d6f31652368b6, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=IDTechEx研究显示：可穿戴设备的未来是医疗, objectType=article, longId=178952, objectId=62b51e895280, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62b51e895280, replyNumber=0, likeNumber=96, createdTime=2020-01-31, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62b51e895280, moduleTitle=IDTechEx研究显示：可穿戴设备的未来是医疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62b51e895280)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652317, encodeId=5cff165231e3a, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Cytotechnology：Wharton果冻间充质基质细胞的醛脱氢酶活性, objectType=article, longId=158998, objectId=69aa158998c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69aa158998c1, replyNumber=0, likeNumber=65, createdTime=2019-05-31, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69aa158998c1, moduleTitle=Cytotechnology：Wharton果冻间充质基质细胞的醛脱氢酶活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69aa158998c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652378, encodeId=f2e316523e839, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=2019Medtec中国展闭幕，2020升级两馆助力中国医疗器械产业创新发展, objectType=article, longId=181415, objectId=056d181415d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=056d181415d2, replyNumber=0, likeNumber=61, createdTime=2020-07-19, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=056d181415d2, moduleTitle=2019Medtec中国展闭幕，2020升级两馆助力中国医疗器械产业创新发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=056d181415d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652376, encodeId=374a16523e6cf, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=英国NICE对罗氏的PD-L1单抗Tecentriq治疗晚期乳腺癌say, objectType=article, longId=180564, objectId=58f6180564c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58f6180564c6, replyNumber=0, likeNumber=66, createdTime=2020-06-21, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58f6180564c6, moduleTitle=英国NICE对罗氏的PD-L1单抗Tecentriq治疗晚期乳腺癌say, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58f6180564c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652305, encodeId=668816523053d, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=罗氏向欧盟提起申请：Tecentriq与Avastin联合治疗肾细胞癌, objectType=article, longId=153843, objectId=27431538430e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27431538430e, replyNumber=0, likeNumber=61, createdTime=2019-05-15, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27431538430e, moduleTitle=罗氏向欧盟提起申请：Tecentriq与Avastin联合治疗肾细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27431538430e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652324, encodeId=655e165232402, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Calypso Biotech获得2000万欧元融资以开发IL-15单抗治疗自身免疫性疾病, objectType=article, longId=160663, objectId=367416066333, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=367416066333, replyNumber=0, likeNumber=73, createdTime=2019-09-06, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=367416066333, moduleTitle=Calypso Biotech获得2000万欧元融资以开发IL-15单抗治疗自身免疫性疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=367416066333)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652355, encodeId=2aed165235590, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Midatech宣布其MidaCore金纳米粒子糖尿病疫苗的首项人体研究安全性结果, objectType=article, longId=175958, objectId=e9801e59581e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9801e59581e, replyNumber=0, likeNumber=61, createdTime=2020-05-27, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9801e59581e, moduleTitle=Midatech宣布其MidaCore金纳米粒子糖尿病疫苗的首项人体研究安全性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9801e59581e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652311, encodeId=251c16523112c, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Nat Biotechnol：重磅！科学家开发出新型微型传感器或有望加速癌症的诊断, objectType=article, longId=155890, objectId=dba81558904f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dba81558904f, replyNumber=0, likeNumber=74, createdTime=2019-02-14, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dba81558904f, moduleTitle=Nat Biotechnol：重磅！科学家开发出新型微型传感器或有望加速癌症的诊断, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dba81558904f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652327, encodeId=d864165232e6d, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Nat Biotechnol：研究不能重复？可能是HeLa细胞系“变”了, objectType=article, longId=161398, objectId=7088161398c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7088161398c8, replyNumber=0, likeNumber=64, createdTime=2019-03-25, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7088161398c8, moduleTitle=Nat Biotechnol：研究不能重复？可能是HeLa细胞系“变”了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7088161398c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652372, encodeId=4ef416523e228, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Artif Cells Nanomed Biotechnol ：CTRP3抑制高浓度葡萄糖诱导的视网膜色素上皮细胞的氧化应激和细胞凋亡, objectType=article, longId=180206, objectId=77da18020613, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77da18020613, replyNumber=0, likeNumber=85, createdTime=2019-10-18, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77da18020613, moduleTitle=Artif Cells Nanomed Biotechnol ：CTRP3抑制高浓度葡萄糖诱导的视网膜色素上皮细胞的氧化应激和细胞凋亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77da18020613)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652325, encodeId=85ba165232589, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=NEJM：sacituzumab govitecan-hziy治疗难治性转移性三阴性乳腺癌, objectType=article, longId=160705, objectId=9197160e05e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9197160e05e2, replyNumber=0, likeNumber=66, createdTime=2019-11-08, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9197160e05e2, moduleTitle=NEJM：sacituzumab govitecan-hziy治疗难治性转移性三阴性乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9197160e05e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652339, encodeId=6dae16523397a, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Genentech与Parvus结成了8亿美元的自身免疫性疾病药物研发联盟, objectType=article, longId=166331, objectId=b5b416633140, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5b416633140, replyNumber=0, likeNumber=58, createdTime=2019-11-29, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5b416633140, moduleTitle=Genentech与Parvus结成了8亿美元的自身免疫性疾病药物研发联盟, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5b416633140)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652298, encodeId=271e165229830, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Health Technol Assess：脓毒症休克儿童：限制性液体单次给予10 ml vs 20 ml, objectType=article, longId=151459, objectId=493115145990, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=493115145990, replyNumber=0, likeNumber=71, createdTime=2019-07-10, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=493115145990, moduleTitle=Health Technol Assess：脓毒症休克儿童：限制性液体单次给予10 ml vs 20 ml, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=493115145990)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652364, encodeId=4f0c1652364e0, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=加拿大卫生部批准罗氏PD-L1单抗Tecentriq治疗小细胞肺癌，这是20年来加拿大批准治疗该疾病的新疗法, objectType=article, longId=177619, objectId=7d301e761945, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d301e761945, replyNumber=0, likeNumber=65, createdTime=2020-03-17, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d301e761945, moduleTitle=加拿大卫生部批准罗氏PD-L1单抗Tecentriq治疗小细胞肺癌，这是20年来加拿大批准治疗该疾病的新疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d301e761945)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652358, encodeId=826516523589d, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=FDA、中检院等权威机构的知名演讲嘉宾确认出席2019Medtec中国展, objectType=article, longId=176478, objectId=b3b31e64783f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3b31e64783f, replyNumber=0, likeNumber=51, createdTime=2019-10-21, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3b31e64783f, moduleTitle=FDA、中检院等权威机构的知名演讲嘉宾确认出席2019Medtec中国展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3b31e64783f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652369, encodeId=2b98165236961, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Nat Biotech：美新研究可大幅增加活体肝脏体外保存时间, objectType=article, longId=179338, objectId=a96e1e9338f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a96e1e9338f6, replyNumber=0, likeNumber=66, createdTime=2020-03-02, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a96e1e9338f6, moduleTitle=Nat Biotech：美新研究可大幅增加活体肝脏体外保存时间, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a96e1e9338f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652347, encodeId=0964165234eab, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=BioNTech启动其双特异性抗体DuoBody-PD-L1x4-1BB的首次人体I / IIa期试验, objectType=article, longId=168717, objectId=5016168e17c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5016168e17c6, replyNumber=0, likeNumber=62, createdTime=2020-02-08, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5016168e17c6, moduleTitle=BioNTech启动其双特异性抗体DuoBody-PD-L1x4-1BB的首次人体I / IIa期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5016168e17c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652320, encodeId=32c21652320b0, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Nanotechnology：通过空气等离子体处理形成掺杂有银纳米颗粒的聚己内酯电纺纳米纤维可有效抗菌, objectType=article, longId=159550, objectId=d9ef15955062, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9ef15955062, replyNumber=0, likeNumber=76, createdTime=2019-06-21, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9ef15955062, moduleTitle=Nanotechnology：通过空气等离子体处理形成掺杂有银纳米颗粒的聚己内酯电纺纳米纤维可有效抗菌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9ef15955062)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652330, encodeId=f6c9165233035, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Biotechnol Rep：植物来源的重组骨桥蛋白-Fc融合蛋白可增强骨生成, objectType=article, longId=162053, objectId=1ece162053a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ece162053a6, replyNumber=0, likeNumber=62, createdTime=2019-05-12, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ece162053a6, moduleTitle=Biotechnol Rep：植物来源的重组骨桥蛋白-Fc融合蛋白可增强骨生成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ece162053a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

TEC

2020-05-29

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Health Technol Assess：难治性抑郁，SSRI或SNRI加用米氮平无效

2019-05-03

shock_melon (审核中...)

前往app查看评论内容

#TEC#

IDTechEx研究显示：可穿戴设备的未来是医疗

2020-01-31

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Cytotechnology：Wharton果冻间充质基质细胞的醛脱氢酶活性

2019-05-31

shock_melon (审核中...)

前往app查看评论内容

#TEC#

2019Medtec中国展闭幕，2020升级两馆助力中国医疗器械产业创新发展

2020-07-19

shock_melon (审核中...)

前往app查看评论内容

#TEC#

英国NICE对罗氏的PD-L1单抗Tecentriq治疗晚期乳腺癌say

2020-06-21

shock_melon (审核中...)

前往app查看评论内容

#TEC#

罗氏向欧盟提起申请：Tecentriq与Avastin联合治疗肾细胞癌

2019-05-15

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Calypso Biotech获得2000万欧元融资以开发IL-15单抗治疗自身免疫性疾病

2019-09-06

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Midatech宣布其MidaCore金纳米粒子糖尿病疫苗的首项人体研究安全性结果

2020-05-27

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Nat Biotechnol：重磅！科学家开发出新型微型传感器或有望加速癌症的诊断

2019-02-14

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Nat Biotechnol：研究不能重复？可能是HeLa细胞系“变”了

2019-03-25

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Artif Cells Nanomed Biotechnol ：CTRP3抑制高浓度葡萄糖诱导的视网膜色素上皮细胞的氧化应激和细胞凋亡

2019-10-18

shock_melon (审核中...)

前往app查看评论内容

#TEC#

NEJM：sacituzumab govitecan-hziy治疗难治性转移性三阴性乳腺癌

2019-11-08

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Genentech与Parvus结成了8亿美元的自身免疫性疾病药物研发联盟

2019-11-29

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Health Technol Assess：脓毒症休克儿童：限制性液体单次给予10 ml vs 20 ml

2019-07-10

shock_melon (审核中...)

前往app查看评论内容

#TEC#

加拿大卫生部批准罗氏PD-L1单抗Tecentriq治疗小细胞肺癌，这是20年来加拿大批准治疗该疾病的新疗法

2020-03-17

shock_melon (审核中...)

前往app查看评论内容

#TEC#

FDA、中检院等权威机构的知名演讲嘉宾确认出席2019Medtec中国展

2019-10-21

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Nat Biotech：美新研究可大幅增加活体肝脏体外保存时间

2020-03-02

shock_melon (审核中...)

前往app查看评论内容

#TEC#

BioNTech启动其双特异性抗体DuoBody-PD-L1x4-1BB的首次人体I / IIa期试验

2020-02-08

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Nanotechnology：通过空气等离子体处理形成掺杂有银纳米颗粒的聚己内酯电纺纳米纤维可有效抗菌

2019-06-21

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Biotechnol Rep：植物来源的重组骨桥蛋白-Fc融合蛋白可增强骨生成

2019-05-12

科室
- - 订阅+
  - 更多科室
工具
服务